The Mementos

NOTICE:

This is a fragment page.

It is an internal page used by the SCP Wiki, and is not meant to be read directly, but included by another. This page should be parented, see above.

Medical Records - Site 19 - Project Amrita

The following medical charts represent the only records that remain from what is thought to have been more than 200 human trials involving variants of RS-Amrita. All other written material in relation to the project was lost or destroyed. The remaining records are presented in chronological order.

Subject No.: 139

Name: Stephen Moore

Administered: RS-Amrita A.16 - standard dosage. Delivery: intravenous. Action: anti-apoptotic.

Time elapsed: 174 days

Observations: Skin samples indicate thickening of cell membranes and accelerated production of corneocytes. Keratin filament network appears to be based on a recombinant keratin variant, with increased strength and resilience and reduced elasticity. Rate of desquamation reduced to 20% of normal levels.

Subject No.: 188

Name: Susan Parker

Time elapsed: 235 days

Observations: Metabolism has decreased to extremely low levels. Red blood cells exhibit greatly increased oxygen storage capacity, resulting in slower blood flow and increased muscle endurance.

Subject No.: 127

Name: Michael Taubman

Time elapsed: 282 days

Observations: Genetic sequencing shows evidence of reduction in telomere shortening. No observable symptoms or health benefits. Subject reports RS-Amrita "tastes like blood".

Subject No.: 85

Name: <illegible>

Time elapsed: 301 days

Observations: Subject rendered spontaneously immobile and non-responsive. No observable respiration or heart rate. Body unable to be moved or manipulated. Cause unclear.

Subject No.: 71

Name: Captain Raymond Lewis

Administered: RS-Amrita B.21 - standard dosage. Delivery: intravenous. Action: <paper torn>

Time elapsed: 370 days

Observations: Subject's health remains stable. Blood results clear. Subject reports increased alertness, vigor and sense of well-being.

Abnormal bone growth in mandible, maxillary and zygomatic regions appears to have stabilised, and remains typical for B.21 patients. Subject reports no major discomfort.

Results of physical testing are attached.



Project Amrita - Interview 071-005

Date: 26 April 1947

Present:

  • O5-1
  • Amrita Test Subject 71 (Raymond Lewis)
  • Lt. Charles Taylor (MTF Alpha-1)

O5-1: Morning, Ray.

Lewis: Good morning, sir - ha, sorry. Taylor, good to see you.

Taylor: Good morning, sir.

O5-1: You can wait outside if you wish, Taylor.

Taylor: I'm afraid not, sir. Protocol for interaction with test subjects.

O5-1: Even him? Okay. Scotch, Ray?

Lewis: I don't think they'll allow it, unfortunately.

O5-1: They don't have to know. No? All right then. So how are you feeling? The team tell me that the latest course is going well.

Lewis: Sure is. Since your last visit, they've changed the formula slightly, and I swear I can feel it. No side effects, other than a bit of an ache in my jaw.

O5-1: I can see the bruising. Do they know what that is?

Lewis: Something about bone density or cartilage elasticity - they don't tell me much. Surprised you can't enlighten me.

O5-1: Sometimes I think they don't want to disappoint me with any bad news. It's why I keep coming to talk to you, to see for myself. That, and the pleasure of your company, of course.

Lewis: Ha. Charming as always. Well my company should be pleasant - I'm feeling pretty great.

O5-1: Really? You're sure?

Lewis: Absolutely. I'm sleeping soundly, the scores on my physicals are up, and I haven't run five miles this quick since I was thirty-five. They've let me train with some of the Alpha-1 boys, and I'm not far off the pace - at my age!

O5-1: You'll show those kids who's boss yet.

Lewis: Well, whatever they've got me on, it's working.

O5-1: You might have a couple less grey hairs, too.

Lewis: Might be. So, what's keeping you busy?

O5-1: Oh, you know, the usual worries. All memetics at the moment. Nothing on the K-scale, but we just lost two good researchers to mercury poisoning.

Lewis: Sorry to hear that.

O5-1: What? Oh, that's okay. It's just the work seems to get more and more dangerous.

Lewis: We're doing the right thing though. We are achieving greatness.

O5-1: I know, but - I shouldn't have asked you to do this. It's too risky.

Lewis: We knew that when we started. It will be worth it.

O5-1: I'm not sure. Look, I shouldn't really tell you this, but - there's been an issue with one of the other Amrita subjects. He -

Lewis: His name was Thomson, right? Yes, I've heard about it.

O5-1: <exhales> Then you'll ask to drop out of the project?

Lewis: No! Sorry sir, but I signed up for this, and I want to see it through.

O5-1: But you've seen him - what it did.

Lewis: That's a different batch, though.

O5-1: On the same project, the same theories.

Lewis: Theories that I'm proving! Don't tell me you've ceased to believe in them?

O5-1: It's not that. But I have doubts -

Lewis: Doubts? Another word for cowardice! Maybe I should -

O5-1: Ray, you know that's not -

Lewis: - that's easy for you to say when -

<cross talk, unintelliglble>

Lewis: - better off dying!

O5-1: Ray! That's exactly what - exactly …

<silence>

Taylor: Sir? Are you all right, sir?

Lewis: I'm sorry. You and me, we'll figure it out. That's what we do. That's why we're here. Sir, you know - <silence, 3 seconds> - you know they would want you to keep going.

O5-1: I hope so. Yes. You're right, of course. Thanks for reminding me. I just worry - I guess I'm getting old.

Lewis: Well, someone has to.

O5-1: Ha. Thanks, Ray. See you next time?

Lewis: I'll be here.



Medical Records - Site 19 - Project Amrita

scan4.PDF
scan12.PDF
scan3.PDF




Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License